Avricore Health Inc. (AVCR.V)
| Previous Close | 0.1800 |
| Open | 0.1800 |
| Bid | 0.1750 x 0 |
| Ask | 0.1800 x 0 |
| Day's Range | 0.1800 - 0.1800 |
| 52 Week Range | 0.1050 - 0.3350 |
| Volume | |
| Avg. Volume | 248,207 |
| Market Cap | 17.98M |
| Beta (5Y Monthly) | -1.88 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0000 |
| Earnings Date | Nov 27, 2024 - Dec 02, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACCESSWIREKeynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25-26, 2024 at the Fairmont Waterfront Vancouver
VANCOUVER, BC / ACCESSWIRE / September 24, 2024 / Planet MicroCap presents the Planet MicroCap Showcase: VANCOUVER taking place on September 25-26, 2024, where 50 MicroCap public and private companies will be presenting at the Fairmont Waterfront ...
Simply Wall St.Avricore Health Second Quarter 2024 Earnings: EPS: CA$0.001 (vs CA$0.003 loss in 2Q 2023)
Avricore Health ( CVE:AVCR ) Second Quarter 2024 Results Key Financial Results Revenue: CA$1.05m (up 91% from 2Q 2023...
GlobeNewswireAvricore Grants Options
VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 3,361,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.29 per common share. All Options were granted pursuant to the Company’s stock option plan and are subject to the terms of th
